Viewing Study NCT03953092


Ignite Creation Date: 2025-12-24 @ 3:50 PM
Ignite Modification Date: 2025-12-25 @ 6:08 PM
Study NCT ID: NCT03953092
Status: COMPLETED
Last Update Posted: 2021-01-11
First Post: 2019-05-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Randomized, Double-blind, Placebo-controlled, Sequential Single and Multiple Ascending Doses of YG1699
Sponsor: Youngene Therapeutics Inc., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module